Legal Representation
Attorney
John M. Mueller
USPTO Deadlines
Next Deadline
2133 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251028)
Due Date
October 28, 2031
Grace Period Ends
April 28, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 28, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 28, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 9, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 9, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 3, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 2, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 2, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 2, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 1, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 22, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 22, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 4, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Mar 4, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Mar 4, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Feb 27, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 27, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders for human use; Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 042
Scientific research for medical purposes in the field of the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 044
Medical treatment services for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; Provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Additional Information
Design Mark
The mark consists of the wording "VERONA PHARMA" in stylized font, with a design of a circle with straight lines in varying lengths emanating out from it, and with three of the straight lines in the upper right of the design detached from the circle.
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"